Site icon Ergosanté

ErgoSanté opens its first international subsidiary to meet the growing demand for its exoskeletons

Anduze, 29 March 2021 - ErgoSanté, a technological player in the social economy dedicated to health and well-being at work, is accelerating its international development with the opening of its first subsidiary, ErgoSchutz, based in Öhringen, Baden-Württemberg, Germany. ErgoSanté is thus establishing itself in the most industrialised country in Europe to distribute its flagship product range for export: exoskeletons dedicated to the protection of industrial workers.

ErgoSanté will present its latest exoskeleton, the HAPO, a posture harness for anyone who needs back assistance and/or whose workstation is considered back-breaking. The HAPO reduces strain on the lumbar region and protects the intervertebral discs by redirecting strain from the upper body to the thighs using fibreglass springs and a support capacity of up to 14kg.

Work-related back disorders have been widely documented in Germany. Companies are particularly sensitive to the return on investment of preventive measures and are looking for solutions to address these increasingly common pathologies. For example, in 2018, the mutual insurance company DAK-Gesundheit produced the report "Rätsel Rücken" ("The back puzzle"), which reveals the following facts:

The DAK-Gesundheit study concludes that the health policy goal of getting the back problem under control has not been achieved. Health and industry need innovative solutions. This is where ErgoSanté comes in, offering companies its range of exoskeletons as well as all its workstation solutions for the industrial and service sectors.

Samuel Corgne, CEO and founder of ErgoSanté, says "Since the release of its exoskeletons in 2019, ErgoSanté has seen strong international interest and is already exporting its products to the US, Italy, Canada and Brazil. We are now accelerating our export development through the opening of new subsidiaries. Germany is the first step in this internationalisation process.

This expansion is supported by a growing global exoskeleton market; analyst firm Research and Markets1 predicts that the global exoskeleton market over the next seven years could reach $4.2 billion by 2027, growing at an annual rate of over 26%.

ABOUT ERGOSANTE

Because despite the progress made by society, work in companies is generating more and more health problems, Ergosanté is improving the working conditions of able-bodied and non-able-bodied people, by bringing technological innovation to the service of the greatest number of people through customised solutions. Ergosanté designs and distributes ergonomic equipment adapted to the specific needs of companies and their employees: its ambition is to offer the best technical solution to health problems in the workplace, including disabilities. Created in 2013, Ergosanté has 90 expert employees in 15 branches to support companies throughout France.

https://www.ergosante.fr

PRESS CONTACTS : Calyptus - Mathieu Calleux / Nicolas Hélin -01 53 65 37 91 / 37 96 --ergosante@calyptus.net

Exit the mobile version